FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 141 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | – | 448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 1,268,805 | $8,742,000 | 8.10% |
| Samsara BioCapital, LLC | 1,565,526 | $10,786,000 | 2.88% |
| Deep Track Capital, LP | 4,050,000 | $27,905,000 | 1.83% |
| RA Capital Management | 9,011,651 | $62,090,000 | 1.66% |
| Cormorant Asset Management, LP | 3,172,204 | $21,856,000 | 1.65% |
| ARMISTICE CAPITAL, LLC | 4,736,000 | $32,631,000 | 0.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 94,386 | $650,000 | 0.20% |
| Parkman Healthcare Partners LLC | 78,603 | $542,000 | 0.20% |
| Integral Health Asset Management, LLC | 130,051 | $896,000 | 0.18% |
| Opaleye Management Inc. | 58,700 | $404,000 | 0.18% |